• Je něco špatně v tomto záznamu ?

Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution

P. Oleksak, E. Nepovimova, M. Valko, S. Alwasel, S. Alomar, K. Kuca

. 2024 ; 108 (-) : 104447. [pub] 20240416

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013685

This review systematically compiles sports-related drugs, substances, and methodologies based on the most frequently detected findings from prohibited lists published annually by the World Anti-Doping Agency (WADA) between 2003 and 2021. Aligned with structure of the 2023 prohibited list, it covers all proscribed items and details the pharmacokinetics and pharmacodynamics of five representatives from each section. Notably, it explores significant metabolites and metabolic pathways associated with these substances. Adverse analytical findings are summarized in tables for clarity, and the prevalence is visually represented through charts. The review includes a concise historical overview of doping and WADA's role, examining modifications in the prohibited list for an understanding of evolving anti-doping measures.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013685
003      
CZ-PrNML
005      
20240905133930.0
007      
ta
008      
240725e20240416ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.etap.2024.104447 $2 doi
035    __
$a (PubMed)38636744
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Oleksak, Patrik $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove 500 03, Czech Republic
245    10
$a Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution / $c P. Oleksak, E. Nepovimova, M. Valko, S. Alwasel, S. Alomar, K. Kuca
520    9_
$a This review systematically compiles sports-related drugs, substances, and methodologies based on the most frequently detected findings from prohibited lists published annually by the World Anti-Doping Agency (WADA) between 2003 and 2021. Aligned with structure of the 2023 prohibited list, it covers all proscribed items and details the pharmacokinetics and pharmacodynamics of five representatives from each section. Notably, it explores significant metabolites and metabolic pathways associated with these substances. Adverse analytical findings are summarized in tables for clarity, and the prevalence is visually represented through charts. The review includes a concise historical overview of doping and WADA's role, examining modifications in the prohibited list for an understanding of evolving anti-doping measures.
650    12
$a doping ve sportu $7 D004300
650    _2
$a lidé $7 D006801
650    _2
$a látky zvyšující výkon $x farmakokinetika $7 D058573
650    _2
$a odhalování abúzu drog $x metody $7 D015813
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove 500 03, Czech Republic
700    1_
$a Valko, Marian $u Faculty of Chemical and Food Technology, Slovak University of Technology, Bratislava 812 37, Slovakia; Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
700    1_
$a Alwasel, Saleh $u Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
700    1_
$a Alomar, Suliman $u Doping Research Chair, Zoology Department, College of Science, King Saud University, Riyadh-11451, Kingdom of Saudi Arabia. Electronic address: syalomar@ksu.edu.sa
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove 500 03, Czech Republic; Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada 18071, Spain. Electronic address: kamil.kuca@uhk.cz
773    0_
$w MED00008557 $t Environmental toxicology and pharmacology $x 1872-7077 $g Roč. 108 (20240416), s. 104447
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38636744 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133924 $b ABA008
999    __
$a ok $b bmc $g 2143465 $s 1225551
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 108 $c - $d 104447 $e 20240416 $i 1872-7077 $m Environmental toxicology and pharmacology $n Environ Toxicol Pharmacol $x MED00008557
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace